News and Events

International Society for Heart and Lung Transplantation (ISHLT) conference 2023!

May 17, 2023
Close On The Heels Of The Recent FDA Approval Of The Software Upgrades To The Freedom Driver, Team SynCardia Was Out In Force At The Annual Conference Of International Society For Heart And Lung Transplantation (ISHLT

Picard Medical and its Subsidiary, SynCardia Systems, a Pioneer in Total Artificial Heart Technology, to Become a Publicly Traded Company via Merger with Altitude Acquisition Corp.

April 24, 2023
SynCardia Manufactures and Distributes the First-and-Only Commercially Available and FDA Approved Total Artificial Heart. SynCardia is Entering a Rapid Growth Phase Supported by New Product Development, Label Expansion, and International Growth.

FDA approves significant Freedom Portable Driver software upgrades from SynCardia Systems Inc.  

February 25, 2023
SynCardia Systems LLC is pleased to announce that the US Food and Drug Administration (FDA) has approved significant software upgrades to the Freedom Portable Driver

Cannula Tear Potential

December 3, 2022
Syncardia is working closely with the FDA to communicate appropriate information to certified centers and corrective actions

The first 50cc temporary Total Artificial Heart implantation supports a child in Canada

July 30, 2022
The heartfelt success story of Mariam Tannous.

American Association of Internal Artificial Organs 2022 Annual Conference

June 8, 2022
SynCardia Systems, LLC, exhibits at the American Society of Artificial Internal Organs annual conference.
loading more...